Swine Fever Vaccine Market Is Estimated To Witness High Growth Owing To Increasing Cases of Swine Fever Outbreaks
![]() |
Swine Fever Vaccine Market |
The
global Swine Fever Vaccine Market is estimated to be valued at US$ 2,724.5
million in 2022 and is expected to exhibit a CAGR of 5.9% over the forecast
period 2022-2030, as highlighted in a new report published by Coherent Market
Insights.
A) Market Overview:
Swine fever, also known as classical swine fever, is a highly contagious viral
disease that affects domestic and wild pigs. It is caused by the classical
swine fever virus (CSFV). The disease can have devastating economic
consequences for the swine industry, leading to mortality, loss of production,
and trade restrictions. Swine
Fever Vaccine Market are used as a preventive measure to control the
spread of the virus and protect pig populations.
The need for swine fever vaccines arises from the increasing cases of swine
fever outbreaks worldwide. These outbreaks not only result in significant
economic losses but also pose a threat to food security. Vaccination plays a
crucial role in preventing the spread of the disease and minimizing its impact
on the swine industry.
B) Market Key Trends:
One key trend observed in the swine fever vaccine market is the development of
advanced vaccines with improved efficacy. Companies are investing in R&D
activities to develop novel vaccines that provide better protection against the
classical swine fever virus. For example, Ceva, a leading player in the market,
has developed a next-generation live attenuated vaccine that offers prolonged
immunity and reduces the risk of vertical transmission.
The growing adoption of combination vaccines is another key trend in the
market. Combination vaccines offer protection against multiple diseases,
including swine fever. These vaccines provide convenience and
cost-effectiveness by reducing the number of injections required and minimizing
stress on pigs. Zoetis Services LLC, a prominent player in the market, offers
combinational vaccines that protect against various swine diseases, including
swine fever.
C) PEST Analysis:
Political: Governments of various countries are implementing stringent
regulations and control measures to prevent and control swine fever outbreaks.
This includes surveillance programs, quarantine measures, and vaccination
campaigns.
Economic: Swine fever outbreaks have a significant impact on the economy,
leading to decreased production and trade restrictions. The cost of disease
control measures, such as vaccination, adds to the economic burden for swine
producers and governments.
Social: Swine fever outbreaks can result in public panic and fear due to the
potential transmission of the virus to humans. This highlights the importance
of effective disease control measures, including vaccination, to ensure public
health and safety.
Technological: Advances in technology have led to the development of more
effective and efficient vaccines. This includes the use of adjuvants, new
vaccine delivery systems, and advanced diagnostic techniques for disease
surveillance.
D) Key Takeaways:
1: The global Swine
Fever Vaccine Market is expected to witness high growth, exhibiting a
CAGR of 5.9% over the forecast period. This growth can be attributed to
increasing cases of swine fever outbreaks globally. The need for preventive
measures, such as vaccination, is driving the demand for swine fever vaccines.
2: In terms of regional analysis, Asia Pacific is expected to be the fastest-growing
and dominating region in the swine fever vaccine market. The region has a large
pig population and has been heavily affected by swine fever outbreaks.
Governments in countries like China and Vietnam are actively implementing
vaccination campaigns to control the spread of the disease.
3: Key players operating in the global swine fever vaccine market include Merck
& Co., Inc. (Merck Animal Health), Ceva, Zoetis Services LLC, Boehringer
Ingelheim International GmbH, Indian Immunologicals Ltd., Bioveta, a.s.,
Komipharm, and EC21 Inc. These players are investing in R&D activities to
develop advanced vaccines and expand their market presence through partnerships
and acquisitions.
In conclusion, the swine fever vaccine market is expected to witness
significant growth due to the increasing cases of swine fever outbreaks
globally. The development of advanced vaccines and the adoption of combination
vaccines are key trends in the market. Governments, swine producers, and
vaccine manufacturers are actively working together to control the spread of
the disease and protect pig populations.
Comments
Post a Comment